Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ARB”

181 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 181 results

Post-approval studies (Phase 4)Study completedNCT04023227
What this trial is testing

Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC

Who this might be right for
Chagas DiseaseHeart Failure
Novartis Pharmaceuticals 922
Post-approval studies (Phase 4)UnknownNCT01377285
What this trial is testing

Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Renal Failure
National Taiwan University Hospital 350
Post-approval studies (Phase 4)Study completedNCT04222686
What this trial is testing

Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients

Who this might be right for
Type 2 Diabetes Mellitus
Yaounde Central Hospital 23
Large-scale testing (Phase 3)Looking for participantsNCT05457283
What this trial is testing

Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

Who this might be right for
Chronic Kidney DiseaseProteinuriaChildren
Bayer 100
Large-scale testing (Phase 3)Study completedNCT00254475
What this trial is testing

Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia

Who this might be right for
Essential HypertensionHypercholesterolemia
Novartis 871
Large-scale testing (Phase 3)Ended earlyNCT04493359
What this trial is testing

Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19

Who this might be right for
Covid19Angiotensin II Receptor Antagonist Adverse Reaction
University of Sao Paulo 18
Not applicableUnknownNCT04364893
What this trial is testing

Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19

Who this might be right for
Corona Virus InfectionCOVID-19
D'Or Institute for Research and Education 700
Not applicableStudy completedNCT04351581
What this trial is testing

Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19

Who this might be right for
Covid-19
University Hospital, Gentofte, Copenhagen 78
Post-approval studies (Phase 4)Ended earlyNCT03686696
What this trial is testing

Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT

Who this might be right for
Myocardial Infarction With Non-obstructive Coronary Arteries
Uppsala University 198
Not applicableUnknownNCT00742066
What this trial is testing

Role of AT1-receptor Blockers in Insulin-induced Vasodilation.

Who this might be right for
HypertensionInsulin ResistanceMicrocirculation
Maastricht University Medical Center 32
Large-scale testing (Phase 3)Study completedNCT02807987
What this trial is testing

Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment

Who this might be right for
Hypertension With Moderate Renal Impairment
Daiichi Sankyo Co., Ltd. 58
Not applicableStudy completedNCT04185857
What this trial is testing

MRA and ARB Treatment in Screening of Primary Aldosteronism

Who this might be right for
Primary Aldosteronism Due to Aldosterone Producing Adenoma
University Hospital Padova 50
Testing effectiveness (Phase 2)Looking for participantsNCT04456816
What this trial is testing

The Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria

Who this might be right for
Nephrotic Syndrome Due to Idiopathic Membranous NephropathySevere Proteinuria Due to Idiopathic Membranous Nephropathy
SynAct Pharma Aps 23
Post-approval studies (Phase 4)Study completedNCT01917149
What this trial is testing

Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy

Who this might be right for
Dilated Cardiomyopathy
Xijing Hospital 480
Not applicableStudy completedNCT01071642
What this trial is testing

The Influence of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Function in Patients Undergoing Non-emergent Coronary Angiography

Who this might be right for
Blood Pressure
Soroka University Medical Center 100
Post-approval studies (Phase 4)Study completedNCT00153101
What this trial is testing

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Who this might be right for
Cardiovascular Diseases
Boehringer Ingelheim 31,546
Large-scale testing (Phase 3)Study completedNCT00250562
What this trial is testing

A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

Who this might be right for
Hypertension
Novartis 1,171
Post-approval studies (Phase 4)Ended earlyNCT03738878
What this trial is testing

Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1

Who this might be right for
Hypertension
Vanderbilt University Medical Center 4
Testing effectiveness (Phase 2)WithdrawnNCT03005184
What this trial is testing

Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2

Who this might be right for
Heart Failure NYHA Class IHeart Failure NYHA Class IIHeart Failure NYHA Class III
Vanderbilt University Medical Center
Not applicableStudy completedNCT05096143
What this trial is testing

A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data

Who this might be right for
Heart Failure
Novartis Pharmaceuticals 42,269
Load More Results